Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
1962 • 4,273 citations
The Pathogenesis of Atherosclerosis
1976 • 2,000 citations
Drugs which inhibit prostaglandin biosynthesis.
1974 • 1,325 citations
Increased platelet thromboxane synthesis in diabetes mellitus.
1981 • 260 citations
Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin
1972 • 249 citations
Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.
1977 • 215 citations
Increased Synthesis of Prostaglandin-E-like Material by Platelets from Patients with Diabetes Mellitus
1977 • 195 citations
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
1980 • 183 citations
Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy
1975 • 167 citations
Diabetes and Atherosclerosis: an Overview
1981 • 146 citations
Thromboxane production and platelet aggregation in diabetic subjects with clinical complications
1980 • 114 citations
Stimulated Platelet Aggregation, Thromboxane B2 Formation and Platelet Sensitivity to Prostacyclin - A Critical Evaluation
1981 • 62 citations
Effect of Vitamin E on Platelet Aggregation in Diabetes Mellitus
1984 • 56 citations
Increased Platelet Arachidonic Acid Metabolism in Diabetes Mellitus
1981 • 34 citations
Platelet Abnormalities in Experimental Diabetes
1979 • 22 citations
Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats
1982 • 11 citations